OmniAb, Inc. (OABI)

CIK 0001846253 · Healthcare · Biotechnology

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q2-2026 8-K (2026-08-06) · 99.1
Q1-2026 8-K (2026-05-07) · 99.1
Latest FY-2025 8-K (2026-03-04) · 99.1
Q3-2025 8-K (2025-11-04) · 99.1
Q2-2025 8-K (2025-08-06) · 99.1
Q1-2025 8-K (2025-05-08) · 99.1
FY-2024 8-K (2025-03-18) · 99.1
Q3-2024 8-K (2024-11-12) · 99.1
Q2-2024 8-K (2024-08-08) · 99.1
Q1-2024 8-K (2024-05-09) · 99.1
FY-2023 8-K (2024-03-20) · 99.1
Q3-2023 8-K (2023-11-09) · 99.1

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover Page
Audit Information
—
Statements
Consolidated Balance Sheets
Consolidated and Combined Balance Sheets
Consolidated Balance Sheets (P)
Consolidated and Combined Balance Sheets (P)
Consolidated Statements of Operations
Consolidated and Combined Statements of Operations and Comprehensive Loss
Consolidated Statements of Comprehensive Loss
Consolidated and Combined Statement of Stockholder's Equity
Consolidated Statements of Stockholder's Equity
Consolidated and Combined Statements of Cash Flows
Consolidated Statements of Cash Flows
Notes
Balance Sheet Account Details
Business Combination
Commitments and Contingencies
Cybersecurity Risk Management and Strategy Disclosure
—
Employee Benefit Plan
—
Fair Value Measurement
Goodwill and Intangible Assets
Goodwill and Intangible Assets, Net
Income Taxes
Insider Trading Arrangements
Insider Trading Policies and Procedures
—
Net Loss Per Share
Organization and Basis of Presentation
Pay Vs Performance Disclosure
Relationship With Former Parent and Related Entities
—
Relationship With Ligand and Related Entities
—
Segment Information
Share-based Compensation
Short-term Investments
Stockholders' Equity
Summary of Significant Accounting Policies